Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-09

FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ketorolac tromethamine from Teva Pharmaceuticals USA, Inc., indicating an approved modification or addition to the p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Teva generic) (Ketorolac tromethamine)

Snippet

SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)